Hikma Pharmaceuticals Share News (HIK)

Hikma Pharmaceuticals Information

Buy HIK Shares
Add HIK to Watchlist
Add HIK to Alert

Share Price Information for Hikma Pharmaceuticals (HIK)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 1,994.00

Bid: 2,004.00

Ask: 2,006.00

Change: 13.00 (0.66%)

Spread: 2.00 (0.10%)

Open: 1,987.00

High: 2,008.00

Low: 1,979.00

Prev. Close: 1,981.00

Last checked at -

LONDON BROKER RATINGS: Barclays cuts Direct Line to equal weight

Thu, 29th Feb 2024 09:18

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

----------

FTSE 100

----------

Berenberg cuts Reckitt Benckiser price target to 5,800 (6,240) pence - 'hold'

----------

Barclays cuts Reckitt price target to 6,000 (6,900) pence - 'overweight'

----------

Jefferies cuts Rio Tinto price target to 6,000 (6,500) pence - 'buy'

----------

RBC raises Hikma Pharmaceuticals price target to 2,375 (2,175) pence - 'sector perform'

----------

FTSE 250

----------

Barclays cuts Direct Line to equal weight (overweight) - price target 219 (188) pence

----------

Deutsche Bank cuts Aston Martin price target to 220 (275) pence - 'hold'

----------

RBC cuts Greencoat UK Wind price target to 190 (200) pence - 'outperform'

----------

SMALL CAP

----------

JPMorgan raises Just Eat Takeaway price target to 1,501 (1,494) EUR - 'neutral'

----------

UBS cuts Just Eat Takeaway price target to 2,170 (2,190) pence - 'buy'

----------

Deutsche Bank cuts Just Eat Takeaway price target to 22 (23) EUR - 'buy'

----------

Barclays raises Just Eat Takeaway price target to 17.30 (15.80) EUR - 'equal weight'

----------

UBS cuts Asos price target to 380 (410) pence - 'neutral'

----------

Barclays cuts BHP Group price target to 2520 (2610) pence - 'equal weight'

----------

Berenberg cuts Jubilee Metals price target to 9 (10) pence - 'buy'

----------

Jefferies cuts BHP Group price target to 2,700 (3,000) pence - 'buy'

----------

Comments and questions to newsroom@alliancenews.com

More News

3 Jan 2023 09:25

Hikma launches version of Xyrem medicine in US for treating narcolepsy

(Alliance News) - Hikma Pharmaceuticals PLC on Tuesday said it launched an authorised generic version of the Xyrem sodium oxybate prescription medicine in the US for treating narcolepsy.

3 Jan 2023 09:24

LONDON BROKER RATINGS: Citigroup cuts Wizz Air; Redburn likes CRH

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning, Monday and late Friday:

3 Jan 2023 09:03

LONDON MARKET OPEN: Stocks jump in first session of 2023

(Alliance News) - Stock prices in London made a strong start to the new year on Tuesday, despite weak Chinese data and the UK suffering a fresh wave of rail strikes.

3 Jan 2023 07:58

LONDON BRIEFING: Stocks called higher; China factory sector shrinks

(Alliance News) - Stocks in London are expected to start a new year on the front foot on Tuesday, after a mixed session in Asia amid weak Chinese economic data.

3 Jan 2023 07:46

Hikma launches generic narcolepsy solution in US

(Sharecast News) - Hikma Pharmaceuticals has launched an authorised generic version of Jazz Pharmaceuticals' 'Xyrem 1', or sodium oxybate oral solution, it announced on Tuesday.

8 Dec 2022 09:48

LONDON BROKER RATINGS: JPMorgan cuts Travis Perkins; BofA likes IAG

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

6 Dec 2022 10:48

RBC Capital Markets starts Hikma at 'outperform'

(Sharecast News) - RBC Capital Markets initiated coverage of Hikma Pharmaceuticals on Tuesday at 'outperform' with a 1,750p price target.

6 Dec 2022 10:26

LONDON BROKER RATINGS: JPMorgan cuts Lloyds but raises Barclays

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

15 Nov 2022 12:10

Credit Suisse initiates coverage of Hikma at 'outperform'

(Sharecast News) - Credit Suisse has initiated coverage of Hikma Pharmaceuticals with an 'outperform' rating.

15 Nov 2022 09:58

LONDON BROKER RATINGS: Jefferies cuts Aston Martin to 'underperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

14 Nov 2022 09:25

LONDON BROKER RATINGS: Credit Suisse cuts Ferrexpo to 'neutral'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

8 Nov 2022 09:39

LONDON BROKER RATINGS: Peel cuts Persimmon; Liberum raises Hammerson

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

3 Nov 2022 11:17

Hikma Pharmaceuticals reiterates 2022 guidance as costs widen

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reiterated annual guidance for all three of its businesses, continuing to expect them to underperform against 2021 due to rising costs.

3 Nov 2022 11:08

With tighter purse strings, is parity less probable for the pound?

STOXX 600 down 1.1%

3 Nov 2022 09:28

Banks, insurance dodge carnage as real estate stocks sink

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at .

Latest Share Chat

Hikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BROKER RATINGS: Barclays cuts Direct Line to equal weight

Login to your account

Quickpicks are a member only feature

Login to your account